Literature DB >> 17985402

Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.

Eric Hachulla1, Pierre Clerson, David Launay, Marc Lambert, Sandrine Morell-Dubois, Viviane Queyrel, Pierre-Yves Hatron.   

Abstract

OBJECTIVE: To describe the natural history of ischemic digital ulcers (DU) in systemic sclerosis (SSc).
METHODS: This single-center, retrospective, longitudinal study identified patients by demographic data, SSc history and type, Rodnan score, tobacco use, presence of autoantibodies, ongoing treatment, and DU history.
RESULTS: One hundred three patients were enrolled, 46 with DU history and 57 without; 2 with DU were excluded. The mean duration of followup from the first non-Raynaud SSc symptoms was 12.3 +/- 6.3 years in patients with DU history and 12.1 +/- 7.0 years in patients without. In 43% of cases, first DU occurred within 1 year following first non-Raynaud SSc symptoms, and within 5 years in 73% of cases. In a multivariate analysis, younger patients at occurrence of first non-Raynaud SSc symptoms (HR = 0.77 per each 5 years older, 95% CI 0.66-0.90) with higher Rodnan scores (HR = 1.21 per 5 points, 95% CI 1.05-1.47) experienced earlier DU occurrences, which were delayed by vasodilator therapy (HR = 0.17, 95% CI 0.09-0.32). Patients with shorter durations between first and second DU episodes, particularly with a second episode within 2 years of the first, experienced a higher yearly incidence of DU episodes (0.85 +/- 0.57 and 0.48 +/- 0.26, respectively, if less or more than 2 yrs; p = 0.04). Throughout the duration of followup, the incidence of finger amputation was 1.2% per patient-year in patients with DU history.
CONCLUSION: Patients who are young at first sign of SSc, with high Rodnan scores and without vasodilator therapy, are at high risk of developing DU. Development of DU typically occurred within 5 years of the first non-Raynaud clinical symptom of SSc in the majority of patients.

Entities:  

Mesh:

Year:  2007        PMID: 17985402

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  46 in total

1.  [Digital ulcers in systemic sclerosis--an interdisciplinary challenge].

Authors:  Franziska Wiesent; Jutta Weinerth
Journal:  Med Klin (Munich)       Date:  2010-09-08

2.  Connective tissue diseases: Treatment of digital ulcers in systemic sclerosis.

Authors:  Sevdalina Lambova; Ulf Müller-Ladner
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

3.  Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists.

Authors:  Tanaka Ngcozana; Voon Ong; Christopher Paul Denton
Journal:  BMJ Case Rep       Date:  2014-03-28

Review 4.  My approach to the treatment of scleroderma.

Authors:  Ami A Shah; Fredrick M Wigley
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

5.  Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.

Authors:  Jelena Blagojevic; G Abignano; J Avouac; L Cometi; M Frerix; S Bellando-Randone; S Guiducci; C Bruni; D Huscher; V K Jaeger; V Lóránd; B Maurer; S Nihtyanova; G Riemekasten; E Siegert; I H Tarner; S Vettori; U A Walker; L Czirják; C P Denton; O Distler; Y Allanore; U Müller-Ladner; A Moggi-Pignone; M Matucci-Cerinic; F Del Galdo
Journal:  Clin Rheumatol       Date:  2019-05-20       Impact factor: 2.980

Review 6.  Raynaud phenomenon and digital ulcers in systemic sclerosis.

Authors:  Michael Hughes; Yannick Allanore; Lorinda Chung; John D Pauling; Christopher P Denton; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2020-02-25       Impact factor: 20.543

7.  The critical need for accurately defining digital ulcers in scleroderma.

Authors:  Wendy Li; Tracy M Frech
Journal:  J Scleroderma Relat Disord       Date:  2017-05-19

8.  Registry evaluation of digital ulcers in systemic sclerosis.

Authors:  Felice Galluccio; Marco Matucci-Cerinic
Journal:  Int J Rheumatol       Date:  2010-08-25

9.  The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients.

Authors:  Edoardo Rosato; Federica Borghese; Simonetta Pisarri; Felice Salsano
Journal:  Clin Rheumatol       Date:  2009-08-20       Impact factor: 2.980

10.  Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study.

Authors:  F Cozzi; E Pigatto; M Rizzo; M Favaro; E Zanatta; S Cardarelli; L Riato; L Punzi
Journal:  Clin Rheumatol       Date:  2013-01-24       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.